Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions - PubMed (original) (raw)
Comparative Study
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Bridget F Grant et al. Arch Gen Psychiatry. 2004 Aug.
Abstract
Background: Uncertainties exist about the prevalence and comorbidity of substance use disorders and independent mood and anxiety disorders.
Objective: To present nationally representative data on the prevalence and comorbidity of DSM-IV alcohol and drug use disorders and independent mood and anxiety disorders (including only those that are not substance induced and that are not due to a general medical condition).
Design: Face-to-face survey.
Setting: The United States.
Participants: Household and group quarters' residents.
Main outcome measures: Prevalence and associations of substance use disorders and independent mood and anxiety disorders.
Results: The prevalences of 12-month DSM-IV independent mood and anxiety disorders in the US population were 9.21% (95% confidence interval [CI], 8.78%-9.64%) and 11.08% (95% CI, 10.43%-11.73%), respectively. The rate of substance use disorders was 9.35% (95% CI, 8.86%-9.84%). Only a few individuals with mood or anxiety disorders were classified as having only substance-induced disorders. Associations between most substance use disorders and independent mood and anxiety disorders were positive and significant (P<.05).
Conclusions: Substance use disorders and mood and anxiety disorders that develop independently of intoxication and withdrawal are among the most prevalent psychiatric disorders in the United States. Associations between most substance use disorders and independent mood and anxiety disorders were overwhelmingly positive and significant, suggesting that treatment for a comorbid mood or anxiety disorder should not be withheld from individuals with substance use disorders.
Similar articles
- Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Petry NM, Stinson FS, Grant BF. Petry NM, et al. J Clin Psychiatry. 2005 May;66(5):564-74. doi: 10.4088/jcp.v66n0504. J Clin Psychiatry. 2005. PMID: 15889941 - Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Stinson FS, et al. Drug Alcohol Depend. 2005 Oct 1;80(1):105-16. doi: 10.1016/j.drugalcdep.2005.03.009. Epub 2005 Apr 18. Drug Alcohol Depend. 2005. PMID: 16157233 - Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature.
Turner S, Mota N, Bolton J, Sareen J. Turner S, et al. Depress Anxiety. 2018 Sep;35(9):851-860. doi: 10.1002/da.22771. Epub 2018 Jul 12. Depress Anxiety. 2018. PMID: 29999576 Free PMC article. Review. - Epidemiologic heterogeneity of common mood and anxiety disorders over the lifecourse in the general population: a systematic review.
Nandi A, Beard JR, Galea S. Nandi A, et al. BMC Psychiatry. 2009 Jun 1;9:31. doi: 10.1186/1471-244X-9-31. BMC Psychiatry. 2009. PMID: 19486530 Free PMC article. Review.
Cited by
- Preexisting risk-avoidance and enhanced alcohol relief are driven by imbalance of the striatal dopamine receptors in mice.
Bocarsly ME, Shaw MJ, Ventriglia E, Anderson LG, Goldbach HC, Teresi CE, Bravo M, Bock R, Hong P, Kwon HB, Khawaja IM, Raman R, Murray EM, Bonaventura J, Burke DA, Michaelides M, Alvarez VA. Bocarsly ME, et al. Nat Commun. 2024 Oct 22;15(1):9093. doi: 10.1038/s41467-024-53414-y. Nat Commun. 2024. PMID: 39438478 Free PMC article. - Incongruent reduction of dopamine transporter availability in different subgroups of alcohol dependence.
Yen CH, Shih MC, Cheng CY, Ma KH, Lu RB, Huang SY. Yen CH, et al. Medicine (Baltimore). 2016 Aug;95(33):e4048. doi: 10.1097/MD.0000000000004048. Medicine (Baltimore). 2016. PMID: 27537550 Free PMC article. - Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010.
Tjagvad C, Clausen T, Handal M, Skurtveit S. Tjagvad C, et al. BMC Psychiatry. 2016 May 27;16:168. doi: 10.1186/s12888-016-0881-y. BMC Psychiatry. 2016. PMID: 27234965 Free PMC article. - Test-retest reliability of self-report measures in a dually diagnosed sample.
Houck JM, Forcehimes AA, Gutierrez ET, Bogenschutz MP. Houck JM, et al. Subst Use Misuse. 2013 Jan;48(1-2):99-105. doi: 10.3109/10826084.2012.731674. Epub 2012 Oct 25. Subst Use Misuse. 2013. PMID: 23098171 Free PMC article. - The Association of Alcohol Use Disorders with Suicidal Ideation and Suicide Attempts in a Population-Based Sample with Mood Symptoms.
Sung YK, La Flair LN, Mojtabai R, Lee LC, Spivak S, Crum RM. Sung YK, et al. Arch Suicide Res. 2016;20(2):219-32. doi: 10.1080/13811118.2015.1004489. Epub 2015 May 1. Arch Suicide Res. 2016. PMID: 25933091 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical